Shah, Sonam N. http://orcid.org/0000-0002-2222-895X
Seger, Diane L.
Fiskio, Julie M.
Horn, John R.
Bates, David W.
Funding for this research was provided by:
Seegnal
Article History
Accepted: 1 February 2021
First Online: 22 February 2021
Declarations
:
: This research was supported by Seegnal (Sayvon, Israel), which had no role in the development of the manuscript.
: John Horn is a consultant to Seegnal US, Inc. and Urovant Sciences, Inc. and is co-author and publisher of <i>The Top 100 Drug Interactions: A Guide to Patient Management</i>. Dr. Bates consults for EarlySense, which makes patient safety monitoring systems; receives cash compensation from CDI (Negev), Ltd, which is a not-for-profit incubator for health information technology startups; receives equity from ValeraHealth, which makes software to help patients with chronic diseases; receives equity from Clew, which makes software to support clinical decision making in intensive care; receives equity from MDClone, which takes clinical data and produces deidentified versions of it; receives equity from AESOP, which makes software to reduce medication error rates; and receives research funding from IBM Watson Health. SN Shah, DL Seger, and JM Fiskio have no conflicts of interest that are directly relevant to the content of this article.
: This was approved by Partners Healthcare IRB.
: Not Applicable.
: Not Applicable.
: Not Applicable.
: Not Applicable.